Martin Maisenhölder
Førsteamanuensis
Sirpa Leppä,
Judit Jørgensen,
Anne Tierens,
Leo Meriranta,
Ingunn Østlie,
Peter de Nully Brown
m.fl.:
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Viola Poeschel,
Gerhard Held,
Marita Ziepert,
Mathias Witzens-Harig,
Harald Holte,
Lorenz Thurner
m.fl.:
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
The Lancet 2019 DOI
Sandra Lockmer,
Bjørn Østenstad,
Hans Hagberg,
Harald Holte,
Ann-Sofie Johansson,
Björn Engelbrekt Wahlin
m.fl.:
Chemotherapy-free initial treatment of advanced indolent lymphoma has durable effect with low toxicity: Results from two Nordic lymphoma group trials with more than 10 years of follow-up
Journal of Clinical Oncology 2018 DOI
Knut Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn-Merete Fagerli,
Ragnhild Sørum Falk
m.fl.:
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma
British Journal of Haematology 2016 DOI
Knut Halvor Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Unn-Merete Fagerli,
Ragnhild Sørum Falk,
Øystein Fluge
m.fl.:
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway
Knut Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn Merete Fagerli,
Øystein Fluge
m.fl.:
Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008
Tidsskrift for Den norske legeforening 2013 DOI
Knut Halvor Bjøro Smeland,
Cecilie E. Kiserud,
Grete Fossum Lauritzsen,
Anne Kirsti Blystad,
Unn-Merete Fagerli,
Øystein Fluge
m.fl.:
High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008
Tidsskrift for Den norske legeforening 2013 DOI
Viggo Jønsson,
Haneef Awan,
Emil Nyquist,
Martin Maisenhölder,
Tom Børge Johannesen,
Bernt Erik Ly
m.fl.:
Familial Hodgkin's Lymphoma in Scandinavia
In Vivo 2011 FULLTEKST
Björn Engelbrekt Wahlin,
Christer Sundström,
Harald Holte,
Hans Hagberg,
Martin Erlanson,
Herman Nilsson-Ehle
m.fl.:
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Clinical Cancer Research 2011 DOI
Marianne Brodtkorb Eide,
Grete Fossum Lauritzsen,
Gunnar Kvalheim,
Arne Kolstad,
Unn-Merete Fagerli,
Martin Maisenhölder
m.fl.:
High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
British Journal of Haematology 2011 DOI
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →